Hotchkis & Wiley Capital Management LLC reduced its stake in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 3.6% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 138,090 shares of the health services provider’s stock after selling 5,110 shares during the period. Hotchkis & Wiley Capital Management LLC owned 0.23% of Maximus worth $12,864,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. Assenagon Asset Management S.A. increased its position in Maximus by 151.6% in the 2nd quarter. Assenagon Asset Management S.A. now owns 233,134 shares of the health services provider’s stock worth $19,980,000 after purchasing an additional 140,481 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in Maximus by 942.9% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock worth $27,707,000 after buying an additional 292,300 shares during the last quarter. SG Americas Securities LLC raised its position in Maximus by 609.6% during the second quarter. SG Americas Securities LLC now owns 14,278 shares of the health services provider’s stock valued at $1,224,000 after acquiring an additional 12,266 shares in the last quarter. Versor Investments LP lifted its stake in Maximus by 213.5% in the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider’s stock valued at $792,000 after acquiring an additional 5,789 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Maximus by 12.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider’s stock worth $86,552,000 after acquiring an additional 102,350 shares in the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Separately, StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a report on Thursday, November 28th.
Maximus Stock Performance
MMS opened at $74.58 on Wednesday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49. The company has a market cap of $4.50 billion, a PE ratio of 14.92 and a beta of 0.73. The stock has a 50-day moving average of $86.17 and a 200-day moving average of $87.49. Maximus, Inc. has a 52-week low of $71.75 and a 52-week high of $93.97.
Maximus Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Shareholders of record on Friday, November 15th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.61%. Maximus’s payout ratio is currently 24.00%.
Insider Buying and Selling at Maximus
In related news, insider Michelle F. Link sold 1,363 shares of the company’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the sale, the insider now directly owns 6,567 shares of the company’s stock, valued at approximately $607,841.52. This represents a 17.19 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.40% of the company’s stock.
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
- Five stocks we like better than Maximus
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Netflix Is On Track To Hit $1,000 By Christmas
- How to Use the MarketBeat Excel Dividend Calculator
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.